DJIA 17,265.99 109.14 0.64%
NASDAQ 4,593.43 31.24 0.68%
S&P 500 2,011.36 9.79 0.49%
market minute promo

Chimerix (NASDAQ: CMRX)



company name or ticker

Chimerix Announces Publication of Positive Phase 2 Results of Brincidofovir (CMX001) in the New Engl

Chimerix Announces Publication of Positive Phase 2 Results of Brincidofovir (CMX001) in the New England Journal of Medicine

Biotech Chimerix Lock-Up Expiration